These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5130066)

  • 1. [Epidemiology of nasopharyngeal cancer].
    Sawaki S
    Naika; 1971 Oct; 28(4):614-7. PubMed ID: 5130066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent advances in the study of the etiology of nasopharyngeal cancer].
    Sawaki S
    Jibiinkoka; 1972 Mar; 44(3):165-77. PubMed ID: 4552662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiology of nasopharyngeal cancer--from the standpoint of natural history of herpes type virus infection].
    Hirayama T; Nishioka K; Kawamura A; Rin T; Nishiyama M
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1360-9. PubMed ID: 4326462
    [No Abstract]   [Full Text] [Related]  

  • 4. A simple modified method of collecting blood on filter paper for anti-HTV test in seroepidemiological studies on nasopharyngeal carcinoma.
    Takada M; Murata M; Goto A; Kawamura A; Hung MH
    Jpn J Exp Med; 1970 Oct; 40(5):391-4. PubMed ID: 4927176
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-EB virus titer in serum of patients with otorhinolaryngology cancer].
    Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Sep; 73(9):1533-6. PubMed ID: 4319400
    [No Abstract]   [Full Text] [Related]  

  • 6. Seroepidemiological studies on nasopharyngeal carcinoma by fluorescent antibody techniques with cultured Burkitt lymphoma cell.
    Kawamura A; Takada M; Goto A; Hamajima K; Sanpe T
    Gan; 1970 Feb; 61(1):55-71. PubMed ID: 4194114
    [No Abstract]   [Full Text] [Related]  

  • 7. [Viruses and nasopharyngeal cancer].
    Ito Y
    Naika; 1970 Sep; 26(3):456-60. PubMed ID: 5473952
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cancers of the nasopharyngeal cavity in Morocco. Epidemiology and circumstances by which they were discovered. Outline of an immunologic study].
    Alj AS; Ouazzani H; Kzadri MT; Nejmi S; Le Noir ; Desgrange
    Rev Laryngol Otol Rhinol (Bord); 1980; 101(9-10):487-92. PubMed ID: 7455418
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etio-epidemiology and natural history of nasopharyngeal neoplasms].
    Barthelme E
    Soins Chir; 1986 Jan; (59):6-9. PubMed ID: 3634430
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiologic approach to cancer of the nasopharynx in Morocco].
    el Gueddari B; Kahlain A; Iraqi A; Tazi H; Sqalli S; Salmi M
    Maghrib Tibbi; 1984 Dec; 6(4):297-305. PubMed ID: 6535896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological investigation on malignant nasopharyngeal tumor in Japan].
    Sawaki S
    Nihon Jibiinkoka Gakkai Kaiho; 1971 Feb; 74(2):404-5. PubMed ID: 5106636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Conditional logistic model multivariate analysis on risk factors of nasopharyngeal carcinoma in Hunan].
    Wang H; Li SQ; Zhang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):356-7, 359. PubMed ID: 16045033
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiologic investigation of nasopharyngeal cancer in migrants.
    Huang XL; Wang ZJ; Luo FT; Hu MX; Gu XY; Gu SJ; Chen HQ
    Chin Med J (Engl); 1982 Oct; 95(10):757-61. PubMed ID: 6817981
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiologic, etiologic and immunologic aspects of nasopharyngeal carcinoma [NPC].
    Gastpar H; Wilmes E; Wolf H
    J Med; 1981; 12(4):257-84. PubMed ID: 6273487
    [No Abstract]   [Full Text] [Related]  

  • 15. Data concerning the action of specific antiherpes immunoglobulins on the evolution of some nasopharyngeal and larynegeal neoplasms.
    Nastac E; Athanasiu P; Predescu E; Hozac M; Stoian M; Chira M
    Virologie; 1977; 28(4):271-6. PubMed ID: 602020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA and nasopharyngeal cancer.
    Simons MJ; Chan SH; Day NE; Wee GB; Shanmugaratnam K
    Prog Clin Biol Res; 1977; 16():145-8. PubMed ID: 905319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
    Liu YX
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):337-9. PubMed ID: 6317314
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cancer of the nasopharynx in Morocco: epidemiological approach].
    el Gueddari B; el Hafed A; Bouih A; el Morchid M; Kahlain A
    IARC Sci Publ; 1984; (63):513-24. PubMed ID: 6536623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of the head and neck. Nasopharyngeal cancer. Epidemiology and etiology.
    Muir CS
    JAMA; 1972 Apr; 220(3):393-4. PubMed ID: 5067110
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nasopharyngeal carcinoma: clinical and therapeutic aspects. I. Introduction and symptomatology].
    Vilas Melero J; Vilas Melero J; Vilas Ribot J; Montserrat Viladiu MJ
    An Otorrinolaringol Ibero Am; 1984; 11(1):19-37. PubMed ID: 6089603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.